Notice of Intent to Sole Source

Solicitation Number: 75N98026Q01028 Solicitation Type: Sole Source (Non-Competitive) Title: Vivid Pioneer Ultrasound System NAICS / Size Standard: 325412/ 1,300 employees

Introduction

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO

AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN

COMPETITION. The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), intends to negotiate and award a purchase order on a noncompetitive sole source basis to GE Healthcare, Inc. to provide Vivid Pioneer Ultrasound System to the Division of Intramural Research in accordance with the following information.

Background Information

The NHLBI currently utilizes GE EchoPac software and requires the compatible Vivid Pioneer

Ultrasound System to provide advanced, high-resolution cardiovascular imaging for clinical assessment and research data. The objective of this acquisition is to ensure continuity of exact data metrics across ongoing longitudinal studies, which rely heavily on GE’s specific imaging architecture and software baselines. The ultrasound system will allow sonographers to perform precise characterizations and complex cardiac measurements required by NHLBI research design and following ongoing data analysis.

Purpose and Objectives

The purpose of this acquisition is to acquire a Vivid Pioneer Ultrasound System to support ongoing clinical and research protocols.

Contractor Requirements

The Contractor shall provide one (1) GE Vivid Pioneer Ultrasound System and shall include:

• System Platform: GE Vivid Pioneer cardiovascular ultrasound platform to ensure full compatibility with existing Echo-Lab data workflows and protocols.

• Advanced Quantification Software: Must include integrated tools for high-frame-rate 2D, Doppler, and advanced 4D heart structures and strain analysis.

• Software Integration: Must feature seamless, native compatibility with the lab's specialized cardiac research analysis software—specifically the EchoPac and TomTec Arena (Ultrasound Workspace) and the Fujifilm Synapse CV PACS architecture—to prevent data discrepancies or translation errors during research analysis.

• Transducer Compatibility: Must fully support existing GE-compatible EchoPac cardiovascular probes.

Sole Source Justification

The National Heart, Lung, and Blood Institute requires one Vivid Pioneer Ultrasound System from GE

Healthcare, Inc. The NHLBI Echo-Lab actively conducts long-term longitudinal clinical research protocols that rely on established baseline imaging metrics and raw-data ultrasound parameters generated specifically by GE's proprietary cardiovascular software architecture. Introducing an alternative or

"equivalent" manufacturer's system would introduce data translation errors and inconsistencies in advanced quantification, such as 4D analysis and myocardial strain measurements, compromising the integrity of peer-reviewed research data. The GE Vivid Pioneer integrates natively with the lab’s existing clinical software infrastructure, including GE EchoPac workstations, Synapse CV PACS, and specialized

TomTec Arena (Ultrasound Workspace) analysis tools. Alternative systems lack the specific proprietary raw-data export paths and intermediate conversion software, or third-party DICOM translation tools introduce data interpolation artifacts that invalidate quantitative strain comparisons.

Regulatory Authority

This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart

12.102 (a), restricting competition. For purchases not exceeding the simplified acquisition threshold, contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available.

FAR Clauses

The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Products and Commercial

Services, applies to this acquisition.

The provision at FAR clause 52.212-2, Evaluation – Commercial Products and Commercial Services, is applicable. The Government will award a contract resulting from this notice to the offeror listed above.

The following factors shall be used to evaluate the offer: The contractor shall demonstrate its ability to provide the services listed that meets the specifications provided above.

FAR clause 52.212-3, Offeror Representations and Certifications – Commercial Items, is applicable. An offeror shall complete only paragraphs (b) of this provision if the offeror has completed the annual representations and certificates electronically via http://www.acquisition.gov. If an offeror has not completed the annual representations and certifications electronically at the System for Award

Management (SAM) website, the offeror shall complete only paragraphs (c) through (p) of this provision.

FAR clause at 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition.

FAR clause at 52.204-13 System for Award Management Maintenance, applies to this acquisition.

The provisions at FAR clause 52.203-17, Contractor Employee Whistleblower Rights, applies to this acquisition.

The provisions at FAR clause 52.222-41, Service Contract Labor Standards, applies to this acquisition.

The provision at FAR clause 52.225-25, Prohibition on Contracting With Entities Engaging in Certain Activities or Transactions Relating to Iran—Representation and Certifications, applies to this acquisition.

FAR clause FAR 52.232-33, Payment by Electronic Funds Transfer—System for Award Management, applies to this acquisition.

HHSAR clause 352.239-78, Information and Communication Technology Accessibility Notice

HHSAR clause 352.239-79, Information and Communication Technology Accessibility

HHSAR clause 352.232-71, Electronic Submission of Payment Requests

Additional Information

The North American Industry Classification System (NAICS) Code is 325412 and the Small Business Size

Standard is 1,300 employees. This acquisition is being conducted under RFO FAR Part 12, Acquisition of

Commercial Products and Commercial Services, therefore the requirements of FAR Part 6, Competitive

Requirements, are not applicable and the resultant award will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01 effective March 13, 2026.

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity Identifier

(UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by September 07, 2026, at 12:00PM ED and must reference synopsis number 75N98026Q01028. Responses shall be submitted electronically to noelle.decenzo@nih.gov.

Responses will only be accepted if dated and signed by an authorized company representative. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.

http://www.sam.gov/ mailto:noelle.decenzo@nih.gov